Progressing TAAR-1, Dopamine, and Norepinephrine in Depression Using Solriamfetol

PHASE3CompletedINTERVENTIONAL
Enrollment

346

Participants

Timeline

Start Date

March 18, 2024

Primary Completion Date

December 31, 2024

Study Completion Date

March 26, 2025

Conditions
Major Depressive Disorder
Interventions
DRUG

Solriamfetol 300 mg

Solriamfetol tablets, taken once daily

DRUG

Placebo

Placebo tablets, taken once daily

Trial Locations (40)

10314

Clinical Research Site, Staten Island

11235

Clinical Research Site, Brooklyn

14609

Clinical Research Site, Rochester

19063

Clinical Research Site, Media

19104

Clinical Research Site, Philadelphia

28601

Clinical Research Site, Hickory

32256

Clinical Research Site, Jacksonville

32801

Clinical Research Site, Orlando

32806

Clinical Research Site, Orlando

32807

Clinical Research Site, Orlando

33012

Clinical Research Site, Hialeah

33511

Clinical Research Site, Brandon

38119

Clinical Research Site, Memphis

45215

Clinical Research Site, Cincinnati

60634

Clinical Research Site, Chicago

63304

Clinical Research Site, Saint Charles

66210

Clinical Research Site, Overland Park

70115

Clinical Research Site, New Orleans

72211

Clinical Research Site, Little Rock

73116

Clinical Research Site, Oklahoma City

75231

Clinical Research Site, Dallas

76309

Clinical Research Site, Wichita Falls

77546

Clinical Research Site, Friendswood

78737

Clinical Research Site, Austin

89102

Clinical Research Site, Las Vegas

90015

Clinical Research Site, Los Angeles

90501

Clinical Research Site, Torrance

90706

Clinical Research Site, Bellflower

91316

Clinical Research Site, Encino

91403

Clinical Research Site, Sherman Oaks

91763

Clinical Research Site, Montclair

91786

Clinical Research Site, Upland

91945

Clinical Research Site, Lemon Grove

92056

Clinical Research Site, Oceanside

92374

Clinical Research Site, Redlands

92506

Clinical Research Site, Riverside

94596

Clinical Research Site, Walnut Creek

98201

Clinical Research Site, Everett

06416

Clinical Research Site, Cromwell

02131

Clinical Research Site, Boston

Sponsors
All Listed Sponsors
lead

Axsome Therapeutics, Inc.

INDUSTRY